| 1 | Eustachian tube disorders (PheCode 381.2) | GCST90475904 | 179.73 |
| 2 | COX5B/METAP1D ratio | GCST90314201 | 148.78 |
| 3 | DECR1/STX8 ratio | GCST90314452 | 145.36 |
| 4 | CCL22 levels | GCST90240490 | 138.39 |
| 5 | CALCOCO1/TBC1D5 ratio | GCST90313610 | 126.63 |
| 6 | Hypertensive Heart Disease | FING00000639 | 120.28 |
| 7 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 110.33 |
| 8 | Acne | FING00000010 | 105.07 |
| 9 | Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) | FING00000316 | 103.83 |
| 10 | CERT/MAX ratio | GCST90314028 | 96.95 |
| 11 | Seborrhoeic keratosis | FING00001283 | 96.18 |
| 12 | MAVS/MYO9B ratio | GCST90315390 | 94.69 |
| 13 | Triacylglycerol (48:2) [NL-16:0] levels | GCST90025143 | 92.92 |
| 14 | Plasma X-24947 levels in chronic kidney disease | GCST90266816 | 91.33 |
| 15 | CD48 levels | GCST90425676 | 87.46 |
| 16 | MITD1/WWP2 ratio | GCST90315458 | 84.71 |
| 17 | Osteoarthritis | GCST90476383 | 84.44 |
| 18 | PLXNA4/USP8 ratio | GCST90315690 | 83.07 |
| 19 | DTI autoptx MD unc l tract | GCST90385245 | 79.57 |
| 20 | CALCOCO1/CRACR2A ratio | GCST90313598 | 76.17 |
| 21 | DTI autoptx L2 unc l tract | GCST90385191 | 75.33 |
| 22 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 73.75 |
| 23 | CERT/PRTFDC1 ratio | GCST90314029 | 71.81 |
| 24 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 71.33 |
| 25 | DNMBP/TJAP1 ratio | GCST90314521 | 70.69 |
| 26 | RFC4 levels | GCST90470460 | 70.27 |
| 27 | Other specified and unspecified disorders of lens | FING00001101 | 68.43 |
| 28 | DFFA/SIRT2 ratio | GCST90314462 | 67.81 |
| 29 | HNRNPK/USP8 ratio | GCST90315070 | 67.04 |
| 30 | ICD10 N84: Polyp of female genital tract | GCST90454216 | 66.79 |
| 31 | Reaction time | GCST003499 | 66.00 |
| 32 | MAX/TDRKH ratio | GCST90315406 | 64.42 |
| 33 | CLEC1A levels | GCST90424231 | 62.19 |
| 34 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73 | ECGA000073 | 61.38 |
| 35 | FOXO3/SH2B3 ratio | GCST90314881 | 61.06 |
| 36 | CDK8_CCNC levels | GCST90240825 | 60.86 |
| 37 | Hard cheese liking | GCST90094778 | 59.74 |
| 38 | ADH4/KRT18 ratio | GCST90313192 | 59.58 |
| 39 | TNFRSF11B levels | GCST90243158 | 59.42 |
| 40 | Benign lipomatous neoplasm | FING00000146 | 58.98 |
| 41 | Right-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302831 | 57.67 |
| 42 | IL27 levels | GCST90012017 | 57.00 |
| 43 | MAX/STK24 ratio | GCST90315404 | 56.73 |
| 44 | QC dMRI-to-T1 linear alignment discrepancy | GCST90006351 | 55.76 |
| 45 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475 | ECGU000475 | 55.39 |
| 46 | COMP/THBS4 ratio | GCST90314193 | 54.18 |
| 47 | Psoriasis (vulgaris), strict definition | FING00001223 | 54.01 |
| 48 | Benign neoplasm of other and unspecified endocrine glands | FING00000159 | 53.92 |
| 49 | Urine X-24798 levels in chronic kidney disease | GCST90266802 | 53.60 |
| 50 | Glycated hemoglobin levels | GCST90566424 | 52.31 |
| 51 | X-18601 levels | GCST90243501 | 52.18 |
| 52 | CASP10/PRTFDC1 ratio | GCST90313627 | 52.09 |
| 53 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474 | ECGU000474 | 51.40 |
| 54 | Turnip liking | GCST90094861 | 51.14 |
| 55 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 50.92 |
| 56 | COX5B/FXN ratio | GCST90314199 | 50.07 |
| 57 | CD74/DLL1 ratio | GCST90313891 | 49.88 |
| 58 | APOL1 levels | GCST90468341 | 49.86 |
| 59 | Noninfectious gastroenteritis | digestive | UKBB00000526 | 49.81 |
| 60 | Skin brightness | GCST90502777 | 49.81 |
| 61 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 49.33 |
| 62 | CFI levels | GCST90468730 | 48.96 |
| 63 | How many years have you or did you smoke cigarettes? (inv-normal transformed) | GCST90476390 | 48.66 |
| 64 | CDSN/KLK8 ratio | GCST90313996 | 48.57 |
| 65 | STX8/USP8 ratio | GCST90315896 | 48.18 |
| 66 | aparc-a2009s rh volume G+S-subcentral | GCST90003002 | 47.87 |
| 67 | NFX1 levels | GCST90470041 | 47.74 |
| 68 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 47.11 |
| 69 | METAP1D/PLXNA4 ratio | GCST90315427 | 47.10 |
| 70 | VEGFA levels | GCST90011995 | 47.05 |
| 71 | ICD10 N92: Excessive, frequent and irregular menstruation | GCST90454221 | 46.81 |
| 72 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 46.59 |
| 73 | Marzipan liking | GCST90094797 | 45.67 |
| 74 | Adenocarcinoma and papilloma adenocarcinoma of rectum | FING00000039 | 45.56 |
| 75 | Basophil percentage of white cells variance | GCST90565688 | 44.84 |
| 76 | Viral warts & HPV (PheCode 78) | GCST90475555 | 44.82 |
| 77 | Gamma-CEHC levels | GCST90199864 | 44.28 |
| 78 | CD40LG/EGF ratio | GCST90313819 | 43.76 |
| 79 | Retinal detachments and breaks | FING00001260 | 43.62 |
| 80 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473 | ECGU000473 | 43.61 |
| 81 | SF3B4/SIRT2 ratio | GCST90315838 | 43.32 |
| 82 | BANK1/FOXO1 ratio | GCST90313456 | 42.93 |
| 83 | LEP levels | GCST003368 | 42.52 |
| 84 | INPP1/NT5C3A ratio | GCST90315177 | 42.50 |
| 85 | Cardiac dysrhythmias | circulatory system | UKBB00000119 | 42.44 |
| 86 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476 | ECGU000476 | 42.35 |
| 87 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115 | ECGU000115 | 42.27 |
| 88 | SCAMP3/STX4 ratio | GCST90315805 | 42.25 |
| 89 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 41.69 |
| 90 | IZUMO4 levels | GCST90423792 | 41.67 |
| 91 | Infections of the skin and subcutaneous tissue | FING00000670 | 41.40 |
| 92 | NELL1 levels | GCST90242481 | 41.30 |
| 93 | Unruptured cerebral aneurysm | GCST90018596 | 41.17 |
| 94 | Bullous keratopathy | FING00000231 | 40.96 |
| 95 | Acute peritonitis | FING00000028 | 40.75 |
| 96 | Physical activity (Total log acceleration 12am-2am) | GCST90061409 | 40.69 |
| 97 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72 | ECGA000072 | 40.47 |
| 98 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223 | ECGU000223 | 40.44 |
| 99 | FGR levels | GCST90469236 | 40.36 |
| 100 | ANXA3 levels | GCST90468318 | 40.28 |
| 101 | PLAU/PLAUR ratio | GCST90315674 | 40.00 |
| 102 | BACH1/CNST ratio | GCST90313436 | 39.92 |
| 103 | SFRP2 levels | GCST90242727 | 39.89 |
| 104 | CD74/IL18BP ratio | GCST90313892 | 39.85 |
| 105 | Mean corpuscular hemoglobin concentration | GCST004605 | 39.84 |
| 106 | CA4/TGFBR2 ratio | GCST90313588 | 39.79 |
| 107 | aparc-pial lh area postcentral | GCST90003162 | 39.76 |
| 108 | Volume of left medial nucleus | GCST90474976 | 39.74 |
| 109 | NUDT5/RWDD1 ratio | GCST90315580 | 39.69 |
| 110 | Other menopausal disorders | FING00001071 | 39.65 |
| 111 | EREG/GYS1 ratio | GCST90314701 | 39.62 |
| 112 | AKT1S1/MAX ratio | GCST90313230 | 39.56 |
| 113 | DARS1/USP8 ratio | GCST90314407 | 39.43 |
| 114 | Do you currently smoke cigarettes? | GCST90476388 | 39.27 |
| 115 | Phenylalanine levels (UKB data field 23468) | GCST90269565 | 39.15 |
| 116 | 3-hydroxybutyrate levels (UKB data field 23474) | GCST90269571 | 39.14 |
| 117 | Biological Father: Coronary Artery / Coronary Heart Disease | GCST90475241 | 39.07 |
| 118 | APBB1IP/POLR2F ratio | GCST90313300 | 39.05 |
| 119 | CXCL11/ITGB1BP2 ratio | GCST90314335 | 38.96 |
| 120 | Glucose levels | GCST90132724 | 38.63 |
| 121 | LBR/MAD1L1 ratio | GCST90315295 | 38.54 |
| 122 | INPP1/TBCC ratio | GCST90315180 | 38.53 |
| 123 | Clonal haematopoiesis of indeterminate potential (ASXL1 mutation) | GCST90165259 | 38.12 |
| 124 | KIAA2013 levels | GCST90469679 | 38.06 |
| 125 | FUT8/SPARC ratio | GCST90314893 | 37.96 |
| 126 | CALCOCO1/DCTN1 ratio | GCST90313600 | 37.93 |
| 127 | RBM17 levels | GCST90470434 | 37.75 |
| 128 | ATXN10/PRTFDC1 ratio | GCST90313398 | 37.53 |
| 129 | Type of accommodation lived in - A house or bungalow | Household | UKBB00000869 | 37.45 |
| 130 | acne vulgaris | GCST90245818 | 37.45 |
| 131 | Colon cancer | GCST90011811 | 37.18 |
| 132 | SCARF1/SUSD1 ratio | GCST90315811 | 37.07 |
| 133 | Sporadic miscarriage | GCST011888 | 36.88 |
| 134 | 1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels | GCST90200057 | 36.87 |
| 135 | SARG levels | GCST90470526 | 36.84 |
| 136 | End stage renal disease (PheCode 585.32) | GCST90476126 | 36.71 |
| 137 | Retinal vascular disorders | FING00001262 | 36.67 |
| 138 | CCL19 levels | GCST90274765 | 36.58 |
| 139 | DTI autoptx L3 unc l tract | GCST90385218 | 36.41 |
| 140 | Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) | FING00000041 | 36.31 |
| 141 | GP1BA/SIAE ratio | GCST90314959 | 36.09 |
| 142 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116 | ECGU000116 | 35.76 |
| 143 | BA-exvivo rh volume BA1 | GCST90002849 | 35.43 |
| 144 | TRAF2/WWP2 ratio | GCST90315943 | 35.43 |
| 145 | PLXNB3/SNAP23 ratio | GCST90315693 | 35.26 |
| 146 | FAS levels | GCST90427702 | 35.22 |
| 147 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 35.07 |
| 148 | Snoring | GCST009760 | 35.03 |
| 149 | Feeling lonely | GCST006942 | 34.94 |
| 150 | PDGFB/USP8 ratio | GCST90315633 | 34.85 |
| 151 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 34.62 |
| 152 | Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivity | GCST90302733 | 34.47 |
| 153 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 34.38 |
| 154 | Main speciality of consultant (recoded) - Gastroenterology | Summary Administration | UKBB00000415 | 34.28 |
| 155 | Psoriasis | FING00001222 | 34.10 |
| 156 | ALOX15B levels | GCST90617547 | 34.10 |
| 157 | ATXN10/CASP10 ratio | GCST90313396 | 34.01 |
| 158 | CD84/VASH1 ratio | GCST90313920 | 33.88 |
| 159 | AXL/GAS6 ratio | GCST90313419 | 33.83 |
| 160 | MAP4K5/STAMBP ratio | GCST90315382 | 33.66 |
| 161 | Takes medication for enlarged prostate (Benign prostatic hyperplasia)? | GCST90475262 | 33.61 |
| 162 | EREG/TIMP3 ratio | GCST90314708 | 33.59 |
| 163 | GP6/SCARF1 ratio | GCST90314969 | 33.41 |
| 164 | aparc-DKTatlas lh volume caudalmiddlefrontal | GCST90002864 | 33.40 |
| 165 | FKBP4/SIRT2 ratio | GCST90314841 | 33.34 |
| 166 | STK11/USP8 ratio | GCST90315892 | 33.33 |
| 167 | FSTL3/LTBR ratio | GCST90314883 | 33.32 |
| 168 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 33.24 |
| 169 | aparc-pial lh area caudalmiddlefrontal | GCST90003144 | 33.16 |
| 170 | HBEGF levels | GCST90012067 | 33.15 |
| 171 | C8B levels | GCST90468503 | 32.84 |
| 172 | Endometriosis of rectovaginal septum and vagina | FING00000503 | 32.79 |
| 173 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121 | ECGU000121 | 32.77 |
| 174 | Psoriasis vulgaris | FING00001224 | 32.72 |
| 175 | NUDT5/SERPINB1 ratio | GCST90315581 | 32.65 |
| 176 | EFNB2 levels | GCST90469082 | 32.57 |
| 177 | MMP9/PLAUR ratio | GCST90315470 | 32.55 |
| 178 | aparc-DKTatlas lh volume caudalanteriorcingulate | GCST90002863 | 32.39 |
| 179 | Non-seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00000874 | 32.31 |
| 180 | Phenylalanine levels | GCST90092936 | 32.28 |
| 181 | MPHOSPH8/USP8 ratio | GCST90315479 | 32.27 |
| 182 | AARSD1/UBAC1 ratio | GCST90313135 | 32.07 |
| 183 | Heart failure and coronary heart disease | FING00000604 | 32.02 |
| 184 | CHMP6 levels | GCST90468747 | 32.01 |
| 185 | Conduction disorders | FING00000324 | 31.98 |
| 186 | Healthspan | GCST007406 | 31.96 |
| 187 | HBEGF/YES1 ratio | GCST90315039 | 31.89 |
| 188 | ANXA3/ANXA4 ratio | GCST90313278 | 31.81 |
| 189 | CA4/TNFSF12 ratio | GCST90313589 | 31.77 |
| 190 | Other disorders of skin and subcutaneous tissue | FING00001035 | 31.64 |
| 191 | GFRAL levels | GCST90469331 | 31.31 |
| 192 | CSTB levels | GCST90179272 | 31.19 |
| 193 | TMSB10/TXNRD1 ratio | GCST90315925 | 31.18 |
| 194 | DOK2/PPP1R12A ratio | GCST90314536 | 30.99 |
| 195 | Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions) | FING00000101 | 30.97 |
| 196 | CD40LG/GP6 ratio | GCST90313822 | 30.96 |
| 197 | TBCC/WWP2 ratio | GCST90315911 | 30.94 |
| 198 | GRAP2/LACTB2 ratio | GCST90314980 | 30.76 |
| 199 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77 | ECGA000077 | 30.65 |
| 200 | KLK8/LY6D ratio | GCST90315257 | 30.64 |
| 201 | Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) | FING00000771 | 30.63 |
| 202 | IGF2R/RNASET2 ratio | GCST90315132 | 30.62 |
| 203 | CXCL5 levels | GCST90000461 | 30.62 |
| 204 | DTI TBSS FA Posterior thalamic radiation R | GCST90384408 | 30.52 |
| 205 | DECR1/FXN ratio | GCST90314446 | 30.41 |
| 206 | T1 FreeSurfer BA lh BA3a exvivo thickness | GCST90385521 | 30.36 |
| 207 | Plasma 3-hydroxybutyroylglycine** levels in chronic kidney disease | GCST90264488 | 30.31 |
| 208 | GAL levels | GCST90469300 | 30.27 |
| 209 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71 | ECGA000071 | 30.19 |
| 210 | CD40/IGSF8 ratio | GCST90313815 | 30.13 |
| 211 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 29.98 |
| 212 | Normotensive glaucoma | FING00000892 | 29.81 |
| 213 | ATP5IF1/HSPA1A ratio | GCST90313388 | 29.70 |
| 214 | EGF/MPIG6B ratio | GCST90314611 | 29.69 |
| 215 | CD40/TNFRSF14 ratio | GCST90313830 | 29.61 |
| 216 | ARL13B levels | GCST90468363 | 29.51 |
| 217 | CLU levels | GCST90468793 | 29.32 |
| 218 | CD164/NUDT5 ratio | GCST90313742 | 29.12 |
| 219 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 29.06 |
| 220 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478 | ECGU000478 | 29.01 |
| 221 | APP/EGF ratio | GCST90313322 | 29.00 |
| 222 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 29.00 |
| 223 | Acquired foot deformities (PheCode 735) | GCST90476247 | 28.99 |
| 224 | DTI autoptx FA slf r tract | GCST90385134 | 28.95 |
| 225 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74 | ECGA000074 | 28.85 |
| 226 | GYS1/TIA1 ratio | GCST90315004 | 28.81 |
| 227 | HGF/MMP9 ratio | GCST90315056 | 28.75 |
| 228 | aparc-a2009s lh volume G-postcentral | GCST90002952 | 28.74 |
| 229 | FAP/THBS4 ratio | GCST90314785 | 28.60 |
| 230 | Principal component-derived dietary pattern 16 | GCST90133021 | 28.47 |
| 231 | MESD/WWP2 ratio | GCST90315426 | 28.44 |
| 232 | DIABLO/VSIR ratio | GCST90314470 | 28.43 |
| 233 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117 | ECGU000117 | 28.26 |
| 234 | Ankylosing spondylitis, strict definition | FING00000090 | 28.21 |
| 235 | Colon cancer (PheCode 153.2) | GCST90475567 | 28.18 |
| 236 | Deep endometriosis | FING00000382 | 28.02 |
| 237 | SERPINE1/USP8 ratio | GCST90315835 | 27.99 |
| 238 | COMP/TGFBI ratio | GCST90314192 | 27.92 |
| 239 | DCTN1/SCAMP3 ratio | GCST90314433 | 27.88 |
| 240 | Beta-hydroxyisovaleroylcarnitine levels | GCST90199802 | 27.79 |
| 241 | CALCOCO1/VPS53 ratio | GCST90313612 | 27.71 |
| 242 | IDP T1 FIRST right putamen volume | GCST90002441 | 27.69 |
| 243 | FHIT/MAX ratio | GCST90314818 | 27.62 |
| 244 | SERPINE1/VASH1 ratio | GCST90315836 | 27.59 |
| 245 | Urticaria | GCST90018716 | 27.46 |
| 246 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 27.32 |
| 247 | PPP1R12A/TXNDC5 ratio | GCST90315714 | 27.31 |
| 248 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 27.28 |
| 249 | NTF4 levels | GCST90470095 | 27.27 |
| 250 | TEX101 levels | GCST90470832 | 27.24 |
| 251 | DLL1/IL18BP ratio | GCST90314495 | 27.20 |
| 252 | DCTN6 levels | GCST90468960 | 27.19 |
| 253 | CAG-776 abundance in stool | GCST90032297 | 27.18 |
| 254 | CLEC1B/VSIR ratio | GCST90314106 | 27.16 |
| 255 | CMIP levels | GCST90468795 | 27.09 |
| 256 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482 | ECGU000482 | 27.09 |
| 257 | LYN/YES1 ratio | GCST90315351 | 27.07 |
| 258 | CST3/IGFBP6 ratio | GCST90314293 | 27.04 |
| 259 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222 | ECGU000222 | 27.01 |
| 260 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels | GCST90200060 | 26.90 |
| 261 | DRG2/SEMA4D ratio | GCST90314554 | 26.74 |
| 262 | LCN2/RETN ratio | GCST90315308 | 26.69 |
| 263 | PDGFA/USP8 ratio | GCST90315621 | 26.66 |
| 264 | Left ventricular end diastole anterospetal wall thickness | GCST90278519 | 26.64 |
| 265 | COMP/ICAM1 ratio | GCST90314189 | 26.61 |
| 266 | Other and unspecified disorders of vitreous body | FING00000934 | 26.60 |
| 267 | AXL levels | GCST90468406 | 26.49 |
| 268 | CPPED1 levels | GCST90468845 | 26.31 |
| 269 | X-23641 levels | GCST90200603 | 26.30 |
| 270 | Severe, life-threatening illness (confirmatory factor analysis Factor 20) | GCST90309354 | 26.30 |
| 271 | PPIF levels | GCST90470293 | 26.27 |
| 272 | PLAUR levels | GCST90470251 | 26.12 |
| 273 | FKBP5/MITD1 ratio | GCST90314844 | 25.88 |
| 274 | Congenital malformations of the circulatory system | FING00000340 | 25.73 |
| 275 | USP8 levels | GCST90471022 | 25.64 |
| 276 | Tyrosine levels (UKB data field 23469) | GCST90269566 | 25.54 |
| 277 | aparc-a2009s lh area G-postcentral | GCST90003324 | 25.52 |
| 278 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467 | ECGU000467 | 25.49 |
| 279 | CCN2/SERPINB1 ratio | GCST90313715 | 25.49 |
| 280 | DCTN1/FXN ratio | GCST90314430 | 25.46 |
| 281 | DTI autoptx L2 ptr r tract | GCST90385186 | 25.46 |
| 282 | IDI2 levels | GCST90469505 | 25.44 |
| 283 | Emotional abuse | GCST90551845 | 25.37 |
| 284 | Lupus erythematosus | FING00000739 | 25.34 |
| 285 | Dermatitis due to ingested food | FING00000403 | 25.32 |
| 286 | Potatoes liking | GCST90094816 | 25.29 |
| 287 | FUT8/RSPO1 ratio | GCST90314891 | 25.27 |
| 288 | aparc-Desikan lh volume caudalmiddlefrontal | GCST90002771 | 25.20 |
| 289 | Myo-inositol levels | GCST90243527 | 25.07 |
| 290 | GLOD4/HSPA1A ratio | GCST90314937 | 24.81 |
| 291 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114 | ECGU000114 | 24.77 |
| 292 | aparc-DKTatlas lh volume rostralmiddlefrontal | GCST90002887 | 24.75 |
| 293 | Pelvic width | GCST90448911 | 24.73 |
| 294 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite level | GCST90616403 | 24.68 |
| 295 | Peritonsillar abscess | FING00001160 | 24.65 |
| 296 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 24.53 |
| 297 | 1-(1-enyl-palmitoyl)-GPC (p-16:0) levels | GCST90199899 | 24.49 |
| 298 | SKAP2/VSIR ratio | GCST90315849 | 24.46 |
| 299 | IDP dMRI TBSS MO Posterior limb of internal capsule L | GCST90003971 | 24.45 |
| 300 | Raw carrot liking | GCST90094818 | 24.38 |
| 301 | IDP dMRI TBSS MO Posterior limb of internal capsule R | GCST90003970 | 24.27 |
| 302 | CRADD/HSPA1A ratio | GCST90314239 | 24.17 |
| 303 | DTI autoptx FA fmi tract | GCST90385123 | 24.14 |
| 304 | CD84/GP6 ratio | GCST90313914 | 24.14 |
| 305 | STK24/TDRKH ratio | GCST90315893 | 24.14 |
| 306 | DOK1 levels | GCST90469028 | 24.09 |
| 307 | GP6/SEMA4D ratio | GCST90314971 | 24.08 |
| 308 | BAG6/USP8 ratio | GCST90313451 | 24.05 |
| 309 | Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activity | UKBB00000873 | 24.01 |
| 310 | MTSS2 levels | GCST90469961 | 24.00 |
| 311 | PRKAR1A/SNAP23 ratio | GCST90315728 | 23.97 |
| 312 | SH2B3/SUGT1 ratio | GCST90315840 | 23.90 |
| 313 | FAM174A levels | GCST90241914 | 23.89 |
| 314 | CRIP2/SNCG ratio | GCST90314262 | 23.88 |
| 315 | DTI autoptx L2 ifo l tract | GCST90385178 | 23.81 |
| 316 | DUSP29 levels | GCST90469052 | 23.80 |
| 317 | Phosphatidylcholine (34:5) levels | GCST90024286 | 23.75 |
| 318 | Cerebrospinal fluid S-1-pyrroline-5-carboxylate levels | GCST90318235 | 23.73 |
| 319 | Suicide or other Intentional self-harm | FING00001345 | 23.71 |
| 320 | Left-hemisphere default mode network to putamen white-matter structural connectivity | GCST90302769 | 23.62 |
| 321 | Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney disease | GCST90265671 | 23.58 |
| 322 | IMPA1/TBCC ratio | GCST90315175 | 23.55 |
| 323 | Plasma propionylcarnitine (C3) levels in chronic kidney disease | GCST90265876 | 23.51 |
| 324 | aparc-pial rh area caudalmiddlefrontal | GCST90003177 | 23.51 |
| 325 | Aplastic anemia | GCST90018574 | 23.50 |
| 326 | DTI TBSS MD Sagittal stratum L | GCST90384603 | 23.50 |
| 327 | Volume of right central nucleus | GCST90475024 | 23.46 |
| 328 | ARNT levels | GCST90468367 | 23.42 |
| 329 | PDZK1 levels | GCST90470203 | 23.34 |
| 330 | ALCAM/SPINT1 ratio | GCST90313242 | 23.31 |
| 331 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80) | GCST90320643 | 23.28 |
| 332 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 23.19 |
| 333 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 23.14 |
| 334 | Phosphatidylglycerol (34:1) levels | GCST90025061 | 23.11 |
| 335 | Red cell distribution width | GCST004621 | 23.10 |
| 336 | Psoriatic arthropathies | FING00001225 | 23.06 |
| 337 | HGF/PLAUR ratio | GCST90315059 | 23.03 |
| 338 | Clonal haematopoiesis of indeterminate potential (TET2 mutation) | GCST90165281 | 22.99 |
| 339 | MYOC levels | GCST90422825 | 22.96 |
| 340 | CAG-776 sp000438195 abundance in stool | GCST90032296 | 22.93 |
| 341 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502597 | 22.83 |
| 342 | Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivity | GCST90302672 | 22.80 |
| 343 | X-17676 levels | GCST90200548 | 22.68 |
| 344 | ILKAP levels | GCST90469608 | 22.67 |
| 345 | PPME1/PSMD9 ratio | GCST90315705 | 22.63 |
| 346 | MICB_MICA/TEK ratio | GCST90315446 | 22.61 |
| 347 | AFM levels | GCST90468249 | 22.60 |
| 348 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 22.58 |
| 349 | CD40 levels | GCST90012065 | 22.58 |
| 350 | ACTA2 levels | GCST90468208 | 22.57 |
| 351 | TNF/TNFRSF1B ratio | GCST90315942 | 22.52 |
| 352 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58 | ECGA000058 | 22.40 |
| 353 | XRCC4 levels | GCST90471085 | 22.38 |
| 354 | Bundle branch block (PheCode 426.3) | GCST90475956 | 22.31 |
| 355 | Arthropathies in other diseases classified elsewhere | FING00000108 | 22.28 |
| 356 | DAPP1/ITGB1BP2 ratio | GCST90314388 | 22.20 |
| 357 | Operation code - squint correction | Operations | UKBB00000566 | 22.13 |
| 358 | Other predominantly sexually transmitted diseases, not elsewhere classified | FING00001089 | 22.09 |
| 359 | DTI autoptx L2 ilf r tract | GCST90385181 | 22.09 |
| 360 | Glaucoma, exfoliation | FING00000580 | 22.03 |
| 361 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T120 | ECGU000120 | 22.03 |
| 362 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 21.98 |
| 363 | Snoring | GCST009761 | 21.95 |
| 364 | Left-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302768 | 21.95 |
| 365 | LCN2/S100A12 ratio | GCST90315309 | 21.86 |
| 366 | aparc-a2009s rh area G+S-subcentral | GCST90003374 | 21.84 |
| 367 | METAP2/USP8 ratio | GCST90315434 | 21.81 |
| 368 | COMP/DPP4 ratio | GCST90314188 | 21.75 |
| 369 | FST levels | GCST90012080 | 21.73 |
| 370 | CASP3/CRKL ratio | GCST90313631 | 21.72 |
| 371 | ARTN levels | GCST90468372 | 21.70 |
| 372 | HJV levels | GCST90469455 | 21.60 |
| 373 | Autorefraction - 6mm strong meridian angle (right) | Eyesight | UKBB00000078 | 21.59 |
| 374 | PSPN levels | GCST90470364 | 21.58 |
| 375 | X-12510--2-aminooctanoic acid levels | GCST90243748 | 21.57 |
| 376 | CST6/GAL ratio | GCST90314302 | 21.54 |
| 377 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T118 | ECGU000118 | 21.48 |
| 378 | aparc-Desikan lh area postcentral | GCST90003094 | 21.42 |
| 379 | Autorefraction - 6mm asymmetry index (left) | Eyesight | UKBB00000073 | 21.42 |
| 380 | Tyrosine levels | GCST90092993 | 21.41 |
| 381 | SPINT1 levels | GCST90241717 | 21.37 |
| 382 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 21.30 |
| 383 | DTI autoptx L3 ifo l tract | GCST90385205 | 21.30 |
| 384 | Retinoschisis and retinal cysts (PheCode 361.2) | GCST90475846 | 21.24 |
| 385 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 21.16 |
| 386 | CLMP/GFRA1 ratio | GCST90314133 | 21.13 |
| 387 | Dihomo-linoleoylcarnitine (C20:2) levels | GCST90200144 | 21.11 |
| 388 | GABARAPL1 levels | GCST90469287 | 21.04 |
| 389 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 20.99 |
| 390 | FHIT/PRTFDC1 ratio | GCST90314823 | 20.98 |
| 391 | Other demyelinating diseases of the central nervous system | FING00000995 | 20.97 |
| 392 | PRTFDC1 levels | GCST90470346 | 20.90 |
| 393 | FOXO1/USP8 ratio | GCST90314879 | 20.89 |
| 394 | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels | GCST90199858 | 20.86 |
| 395 | DNMBP/PTPN1 ratio | GCST90314517 | 20.81 |
| 396 | Neutrophil count | GCST90002351 | 20.66 |
| 397 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 20.60 |
| 398 | EPO/TFRC ratio | GCST90314684 | 20.58 |
| 399 | CPB2 levels | GCST90468840 | 20.58 |
| 400 | REST UKBBICA NET100 1212 | GCST90387066 | 20.56 |
| 401 | Milk type used - Full cream | Diet | UKBB00000468 | 20.55 |
| 402 | Aniseed liking | GCST90094689 | 20.53 |
| 403 | Colorectal cancer (PheCode 153) | GCST008372 | 20.40 |
| 404 | Types of transport used (excluding work) - Walk | Physical activity | UKBB00000879 | 20.26 |
| 405 | Ulcer of lower limb, not elsewhere classified | FING00001385 | 20.23 |
| 406 | Heart failure, strict | FING00000606 | 20.21 |
| 407 | SIRT2/STAT5B ratio | GCST90315846 | 20.16 |
| 408 | APP/NID2 ratio | GCST90313327 | 20.15 |
| 409 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452 | ECGU000452 | 20.15 |
| 410 | ITGB1BP2/WASF1 ratio | GCST90315224 | 20.13 |
| 411 | Total Phosphatidylethanolamine levels | GCST90025207 | 20.11 |
| 412 | DIABLO/PRKAR1A ratio | GCST90314469 | 20.07 |
| 413 | Colorectal cancer (PheCode 153) | GCST90475566 | 20.04 |
| 414 | Exotropia | GCST90572737 | 20.02 |
| 415 | ST6GALNAC2 levels | GCST90240251 | 19.94 |
| 416 | Otitis externa | FING00001128 | 19.93 |
| 417 | SERPINB1/TMSB10 ratio | GCST90315830 | 19.91 |
| 418 | Blood cell traits latent factor 14 (red cell) | GCST90559256 | 19.89 |
| 419 | Red cell distribution width | GCST90002369 | 19.81 |
| 420 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64 | ECGA000064 | 19.78 |
| 421 | PDCD6IP levels | GCST90618969 | 19.76 |
| 422 | STAMBP/WWP2 ratio | GCST90315888 | 19.75 |
| 423 | S100A12 levels | GCST90470513 | 19.74 |
| 424 | CD40LG/MPIG6B ratio | GCST90313825 | 19.72 |
| 425 | TANK levels | GCST90470803 | 19.67 |
| 426 | CX3CL1 levels | GCST90274778 | 19.66 |
| 427 | RBKS levels | GCST90470433 | 19.63 |
| 428 | Nontoxic uninodular goiter (PheCode 241.1) | GCST90475640 | 19.61 |
| 429 | Omega-3 fatty acid levels | GCST90502055 | 19.54 |
| 430 | Acne (PheCode 706.1) | GCST90476211 | 19.53 |
| 431 | Red cell distribution width | GCST90002404 | 19.52 |
| 432 | MAP2K6/MGMT ratio | GCST90315373 | 19.47 |
| 433 | BMPER levels | GCST90468455 | 19.42 |
| 434 | BLVRB/HAGH ratio | GCST90313524 | 19.40 |
| 435 | IL19 levels | GCST90469568 | 19.39 |
| 436 | Saturated fatty acids to total fatty acids percentage | GCST90502685 | 19.38 |
| 437 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 19.33 |
| 438 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 19.29 |
| 439 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T85 | ECGA000085 | 19.22 |
| 440 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481 | ECGU000481 | 19.20 |
| 441 | SF3B4 levels | GCST90470609 | 19.18 |
| 442 | DBNL/HSPA1A ratio | GCST90314418 | 19.16 |
| 443 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78 | ECGA000078 | 19.16 |
| 444 | GRHPR levels | GCST90469400 | 19.14 |
| 445 | DTI autoptx L2 slf l tract | GCST90385187 | 19.08 |
| 446 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81 | ECGU000081 | 19.05 |
| 447 | NEO1 levels | GCST90470029 | 19.02 |
| 448 | CCL13/CCL2 ratio | GCST90313675 | 19.00 |
| 449 | ENAH levels | GCST90469106 | 19.00 |
| 450 | PSME2/RBKS ratio | GCST90315737 | 19.00 |
| 451 | IL7 levels | GCST90469606 | 19.00 |
| 452 | BTN2A1/IL18BP ratio | GCST90313545 | 18.96 |
| 453 | DKK1/SERPINE1 ratio | GCST90314480 | 18.88 |
| 454 | CRKL/PLA2G4A ratio | GCST90314271 | 18.86 |
| 455 | aparc-DKTatlas lh volume postcentral | GCST90002882 | 18.83 |
| 456 | PKLR/UBAC1 ratio | GCST90315660 | 18.77 |
| 457 | T1 FreeSurfer DK lh lateraloccipital area | GCST90385598 | 18.74 |
| 458 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84 | ECGA000084 | 18.70 |
| 459 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320607 | 18.69 |
| 460 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221 | ECGU000221 | 18.68 |
| 461 | NRGN levels | GCST90470083 | 18.63 |
| 462 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 18.62 |
| 463 | COL28A1 levels | GCST90468815 | 18.62 |
| 464 | Corns and callosities (PheCode 700) | GCST90476196 | 18.61 |
| 465 | IDP T1 FAST ROIs L subcallosal cortex | GCST90002503 | 18.54 |
| 466 | Felt very upset when reminded of stressful experience in past month | Traumatic events | UKBB00000243 | 18.53 |
| 467 | aparc-a2009s rh volume G-postcentral | GCST90003026 | 18.47 |
| 468 | aparc-Desikan rh area caudalmiddlefrontal | GCST90003110 | 18.45 |
| 469 | EGF/PPIB ratio | GCST90314612 | 18.45 |
| 470 | Red blood cell (erythrocyte) distribution width | Blood count | UKBB00000748 | 18.42 |
| 471 | AKT2 levels | GCST90468277 | 18.40 |
| 472 | GTPBP2 levels | GCST90469417 | 18.39 |
| 473 | CFB levels | GCST90468723 | 18.31 |
| 474 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 18.30 |
| 475 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 18.30 |
| 476 | T1 FreeSurfer aseg MaskVol-to-eTIV | GCST90384192 | 18.20 |
| 477 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 18.19 |
| 478 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 18.19 |
| 479 | PTPN1/SCAMP3 ratio | GCST90315743 | 18.16 |
| 480 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491 | ECGU000491 | 18.15 |
| 481 | PMVK levels | GCST90470272 | 18.15 |
| 482 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63 | ECGA000063 | 18.08 |
| 483 | Margaroylcarnitine (C17) levels | GCST90199929 | 18.07 |
| 484 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290 | ECGA000290 | 18.07 |
| 485 | SERPINB1/SERPINB9 ratio | GCST90315827 | 18.06 |
| 486 | CCN3/FAP ratio | GCST90313721 | 17.99 |
| 487 | RELL1 levels | GCST90242625 | 17.96 |
| 488 | TBL1X levels | GCST90470815 | 17.95 |
| 489 | Obstructive chronic bronchitis (PheCode 496.21) | GCST90476030 | 17.95 |
| 490 | ANXA3/ENO2 ratio | GCST90313281 | 17.94 |
| 491 | DTI autoptx FA ilf r tract | GCST90385127 | 17.93 |
| 492 | FNDC1 levels | GCST90469256 | 17.93 |
| 493 | USP8/WASF1 ratio | GCST90315944 | 17.88 |
| 494 | APCS levels | GCST90428463 | 17.81 |
| 495 | DTI autoptx FA slf l tract | GCST90385133 | 17.79 |
| 496 | Pollinosis | GCST90018683 | 17.73 |
| 497 | ALDH1A1/RBKS ratio | GCST90313247 | 17.73 |
| 498 | CD2AP/USP8 ratio | GCST90313784 | 17.71 |
| 499 | NOS1 levels | GCST90470062 | 17.70 |
| 500 | GPI levels | GCST90469391 | 17.70 |
| 501 | VNN2 levels | GCST90471044 | 17.64 |
| 502 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62 | ECGA000062 | 17.64 |
| 503 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60 | ECGA000060 | 17.64 |
| 504 | ANGPT1/DKK1 ratio | GCST90313263 | 17.62 |
| 505 | aparc-Desikan lh volume postcentral | GCST90002789 | 17.60 |
| 506 | 3-methyl-2-oxovalerate levels | GCST90243485 | 17.54 |
| 507 | DTI TBSS L3 Sagittal stratum L | GCST90384555 | 17.53 |
| 508 | IRAK1/NFATC1 ratio | GCST90315194 | 17.39 |
| 509 | Non-ischemic cardiomyopathy | FING00000873 | 17.37 |
| 510 | Tiglylcarnitine (C5:1-DC) levels | GCST90199800 | 17.35 |
| 511 | Omega-6 fatty acids to total fatty acids percentage | GCST90502545 | 17.34 |
| 512 | Phosphatidylethanolamine (38:4) levels | GCST90488261 | 17.33 |
| 513 | PLAUR levels | GCST90012051 | 17.31 |
| 514 | Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302779 | 17.28 |
| 515 | AHCY/HSPA1A ratio | GCST90313211 | 17.27 |
| 516 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 17.25 |
| 517 | DTI autoptx L2 ifo r tract | GCST90385179 | 17.22 |
| 518 | aparc-pial lh area rostralmiddlefrontal | GCST90003167 | 17.21 |
| 519 | X-24337 levels | GCST90200629 | 17.21 |
| 520 | CFHR1 levels | GCST90618503 | 17.20 |
| 521 | SCARA5/TNC ratio | GCST90315810 | 17.15 |
| 522 | aparc-DKTatlas rh area caudalmiddlefrontal | GCST90003267 | 17.12 |
| 523 | DTI TBSS MD Uncinate fasciculus R | GCST90384616 | 17.11 |
| 524 | AMBP/EFEMP1 ratio | GCST90313253 | 17.10 |
| 525 | MMP9 levels | GCST90469923 | 17.09 |
| 526 | MAP4K5 levels | GCST90469855 | 17.07 |
| 527 | FADD/PLIN3 ratio | GCST90314772 | 17.06 |
| 528 | CXCL10 levels | GCST90274780 | 17.06 |
| 529 | Disorders of choroid and retina | FING00000438 | 17.05 |
| 530 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T289 | ECGA000289 | 17.03 |
| 531 | SSH3 levels | GCST90470749 | 17.01 |
| 532 | Pain (PheCode 338) | GCST90475836 | 16.91 |
| 533 | DTI TBSS FA Superior longitudinal fasciculus L | GCST90384421 | 16.90 |
| 534 | CST6 levels | GCST90468896 | 16.90 |
| 535 | Androsterone sulfate levels | GCST90200674 | 16.88 |
| 536 | Heart failure and bmi 25plus | FING00000603 | 16.75 |
| 537 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49 | ECGA000049 | 16.72 |
| 538 | CRTAC1 levels | GCST90468870 | 16.67 |
| 539 | Medication use (antiglaucoma preparations and miotics) | GCST90018782 | 16.62 |
| 540 | CSF3 levels | GCST90468886 | 16.60 |
| 541 | End-diastolic bi-ventricular shape (principal component 9) | GCST90448488 | 16.60 |
| 542 | CD84/SDC4 ratio | GCST90313916 | 16.59 |
| 543 | Neutrophill count (UKB data field 30140) | GCST90468092 | 16.56 |
| 544 | EGF levels | GCST90469086 | 16.55 |
| 545 | NFKB1 levels | GCST90470037 | 16.53 |
| 546 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 16.51 |
| 547 | FOLH1 levels | GCST90469258 | 16.47 |
| 548 | 3-methyl-2-oxobutyrate levels | GCST90199677 | 16.45 |
| 549 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57 | ECGA000057 | 16.41 |
| 550 | CETN2/PRTFDC1 ratio | GCST90314030 | 16.41 |
| 551 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61 | ECGA000061 | 16.40 |
| 552 | ADH4 levels | GCST90468244 | 16.39 |
| 553 | FUT8/VEGFC ratio | GCST90314896 | 16.39 |
| 554 | Proline levels | GCST90243457 | 16.39 |
| 555 | FKBP4 levels | GCST90469243 | 16.39 |
| 556 | Androstenediol (3alpha, 17alpha) monosulfate (3) levels | GCST90199856 | 16.38 |
| 557 | GBP6 levels | GCST90241368 | 16.30 |
| 558 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86 | ECGA000086 | 16.29 |
| 559 | CD274/EFNA4 ratio | GCST90313768 | 16.29 |
| 560 | METAP2 levels | GCST90469894 | 16.25 |
| 561 | IDP dMRI TBSS MO Middle cerebellar peduncle | GCST90003952 | 16.24 |
| 562 | Major depressive disorder (probable) | GCST005904 | 16.23 |
| 563 | aparc-Desikan rh volume postcentral | GCST90002822 | 16.22 |
| 564 | ThalamNuclei rh volume PuI | GCST90002738 | 16.20 |
| 565 | F-healthy breakfast food liking (derived food-liking factor) | GCST90094780 | 16.13 |
| 566 | Blood cell traits latent factor 1 (white cell) | GCST90559243 | 16.12 |
| 567 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78 | ECGU000078 | 16.09 |
| 568 | BLVRB/CA3 ratio | GCST90313523 | 16.01 |
| 569 | ODAM levels | GCST90470115 | 15.99 |
| 570 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 15.99 |
| 571 | CCL5/TACC3 ratio | GCST90313707 | 15.98 |
| 572 | GRAP2/TYMP ratio | GCST90314990 | 15.98 |
| 573 | Red cell distribution width | GCST90025988 | 15.98 |
| 574 | DLL4 levels | GCST90469005 | 15.96 |
| 575 | MFGE8 levels | GCST90469900 | 15.89 |
| 576 | Lung cancer | GCST90011812 | 15.88 |
| 577 | Other infective otitis externa | FING00001060 | 15.88 |
| 578 | ASRGL1 levels | GCST90468379 | 15.86 |
| 579 | GRSF1 levels | GCST90469407 | 15.83 |
| 580 | aparc-DKTatlas rh volume postcentral | GCST90002913 | 15.82 |
| 581 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46 | ECGA000046 | 15.78 |
| 582 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122 | ECGU000122 | 15.76 |
| 583 | PPP1R2/USP8 ratio | GCST90315723 | 15.71 |
| 584 | SUGT1/TBL1X ratio | GCST90315897 | 15.67 |
| 585 | Chronic iridocyclitis | FING00000287 | 15.64 |
| 586 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453 | ECGU000453 | 15.52 |
| 587 | NADK/PXN ratio | GCST90315512 | 15.51 |
| 588 | SDK2 levels | GCST90470562 | 15.50 |
| 589 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 15.44 |
| 590 | F11 levels | GCST90469165 | 15.42 |
| 591 | CA4 levels | GCST90468513 | 15.40 |
| 592 | CST3/TIMP1 ratio | GCST90314300 | 15.40 |
| 593 | NUMB levels | GCST90470108 | 15.38 |
| 594 | Bitter ale liking | GCST90094705 | 15.36 |
| 595 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 15.36 |
| 596 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 15.33 |
| 597 | SDC4 levels | GCST90470559 | 15.32 |
| 598 | Mean corpuscular haemoglobin concentration (UKB data field 30060) | GCST90468085 | 15.30 |
| 599 | CCS levels | GCST90468594 | 15.27 |
| 600 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77 | ECGU000077 | 15.25 |
| 601 | EDAR/ITGB1BP2 ratio | GCST90314580 | 15.21 |
| 602 | ALB levels | GCST90018725 | 15.20 |
| 603 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123) | GCST90320686 | 15.13 |
| 604 | IDP T1 FAST ROIs L precentral gyrus | GCST90002463 | 15.07 |
| 605 | SEZ6 levels | GCST90470608 | 14.98 |
| 606 | Honey liking | GCST90094782 | 14.95 |
| 607 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 14.93 |
| 608 | Anal and rectal conditions | digestive | UKBB00000029 | 14.93 |
| 609 | DLK1/FAP ratio | GCST90314491 | 14.92 |
| 610 | FXN levels | GCST90469282 | 14.90 |
| 611 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 14.88 |
| 612 | MITD1 levels | GCST90469910 | 14.87 |
| 613 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488 | ECGU000488 | 14.87 |
| 614 | Neutrophill count | Blood count | UKBB00000497 | 14.86 |
| 615 | CCBL2 levels | GCST90241722 | 14.85 |
| 616 | COMP/ITGAV ratio | GCST90314190 | 14.85 |
| 617 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 14.80 |
| 618 | DNM3 levels | GCST90469022 | 14.80 |
| 619 | VPS4B levels | GCST90471047 | 14.79 |
| 620 | DOK2/LACTB2 ratio | GCST90314532 | 14.79 |
| 621 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70 | ECGA000070 | 14.77 |
| 622 | T1 FreeSurfer DKT lh lateraloccipital area | GCST90384202 | 14.77 |
| 623 | Rubneribacter sp002159915 abundance in stool | GCST90032541 | 14.76 |
| 624 | Eicosenoylcarnitine (C20:1) levels | GCST90200148 | 14.69 |
| 625 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82 | ECGU000082 | 14.69 |
| 626 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 14.67 |
| 627 | Neutrophil count | GCST90002398 | 14.65 |
| 628 | Primary Raynaud’s phenomenon | GCST90271714 | 14.65 |
| 629 | MS-disease / Multiple Sclerosis | FING00000839 | 14.64 |
| 630 | MMP9/OLR1 ratio | GCST90315467 | 14.57 |
| 631 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 14.52 |
| 632 | CLMP/TNFRSF19 ratio | GCST90314136 | 14.51 |
| 633 | IL22RA2 levels | GCST90090699 | 14.51 |
| 634 | DTI autoptx L2 fmi tract | GCST90385177 | 14.50 |
| 635 | CXCL6/DFFA ratio | GCST90314357 | 14.47 |
| 636 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024198 | 14.46 |
| 637 | aparc-DKTatlas rh area precentral | GCST90003287 | 14.45 |
| 638 | EGF/GP6 ratio | GCST90314608 | 14.45 |
| 639 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59 | ECGA000059 | 14.45 |
| 640 | DNA methylation Hannum age acceleration | GCST90014289 | 14.45 |
| 641 | Mandibular retrognathia | FING00000784 | 14.44 |
| 642 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 14.43 |
| 643 | CCN2/MGLL ratio | GCST90313714 | 14.41 |
| 644 | IGSF8/VSIR ratio | GCST90315141 | 14.41 |
| 645 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320898 | 14.36 |
| 646 | Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000167 | 14.35 |
| 647 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76 | ECGA000076 | 14.35 |
| 648 | Degree of unsaturation | GCST90502224 | 14.33 |
| 649 | HGF/TNFSF14 ratio | GCST90315060 | 14.32 |
| 650 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119 | ECGU000119 | 14.27 |
| 651 | APP/PPP1R12A ratio | GCST90313330 | 14.27 |
| 652 | CST6/NECTIN4 ratio | GCST90314303 | 14.25 |
| 653 | GAL/PM20D1 ratio | GCST90314917 | 14.20 |
| 654 | Retinal detachments and breaks | Disorders of choroid and retina | UKBB00000755 | 14.18 |
| 655 | DAPP1/SDC4 ratio | GCST90314399 | 14.16 |
| 656 | Sleep apnea | GCST90475824 | 14.13 |
| 657 | Anorexia (incl.atypical) | FING00000093 | 14.10 |
| 658 | FABP1/RBP2 ratio | GCST90314753 | 14.09 |
| 659 | Plasma X-25279 levels in chronic kidney disease | GCST90266835 | 14.09 |
| 660 | DCTN1/ERBIN ratio | GCST90314429 | 14.09 |
| 661 | Milk type used: Full cream (UKB data field 1418_1) | GCST90132938 | 14.05 |
| 662 | CGA levels | GCST90468732 | 14.04 |
| 663 | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | GCST90200103 | 13.99 |
| 664 | T1 CAT volume Vermis VIIIa | GCST90384128 | 13.97 |
| 665 | SPRR3 levels | GCST90470737 | 13.96 |
| 666 | CD8 on Effector Memory CD8+ T cell | GCST90002056 | 13.95 |
| 667 | GADD45GIP1 levels | GCST90469293 | 13.93 |
| 668 | Deoxycholic acid glucuronide metabolite level | GCST90616229 | 13.93 |
| 669 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 13.92 |
| 670 | Macular pucker | FING00000745 | 13.90 |
| 671 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48 | ECGA000048 | 13.86 |
| 672 | BMP4 levels | GCST90468453 | 13.80 |
| 673 | Sleep disorders | neurological | UKBB00000776 | 13.80 |
| 674 | Epiandrosterone sulfate levels | GCST90199752 | 13.78 |
| 675 | FOXO1/NFATC1 ratio | GCST90314873 | 13.77 |
| 676 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 13.77 |
| 677 | Female genital prolapse | FING00000535 | 13.73 |
| 678 | aparc-Desikan rh thickness postcentral | GCST90003500 | 13.72 |
| 679 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 13.72 |
| 680 | APP/NID1 ratio | GCST90313326 | 13.71 |
| 681 | CD83/LAMP3 ratio | GCST90313906 | 13.71 |
| 682 | Carnitine levels | GCST90239991 | 13.69 |
| 683 | Recent trouble relaxing | Anxiety | UKBB00000745 | 13.68 |
| 684 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226 | ECGU000226 | 13.66 |
| 685 | IDP dMRI TBSS ISOVF Superior corona radiata R | GCST90004501 | 13.63 |
| 686 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T291 | ECGA000291 | 13.63 |
| 687 | Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary Operations | UKBB00000575 | 13.57 |
| 688 | Red cell distribution width | GCST006804 | 13.56 |
| 689 | PLXNA4/SPRY2 ratio | GCST90315687 | 13.56 |
| 690 | ANGPT1/SERPINE1 ratio | GCST90313269 | 13.56 |
| 691 | Other diseases of blood and blood-forming organs, wide | FING00000999 | 13.55 |
| 692 | Operation code - spinal laminectomy | Operations | UKBB00000564 | 13.53 |
| 693 | MAX levels | GCST90469867 | 13.53 |
| 694 | STAMBP levels | GCST90470756 | 13.52 |
| 695 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 13.50 |
| 696 | FKBP4/FKBP5 ratio | GCST90314838 | 13.50 |
| 697 | IRAK1 levels | GCST90469627 | 13.49 |
| 698 | MANF/TXNDC5 ratio | GCST90315370 | 13.47 |
| 699 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 13.46 |
| 700 | Biliverdin levels in chronic kidney disease | GCST90257495 | 13.41 |
| 701 | PDGFB/PTPN6 ratio | GCST90315625 | 13.40 |
| 702 | ARHGEF10 levels | GCST90468357 | 13.38 |
| 703 | Right-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302828 | 13.38 |
| 704 | CASP3/SERPINE1 ratio | GCST90313643 | 13.36 |
| 705 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85 | ECGU000085 | 13.35 |
| 706 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90024195 | 13.35 |
| 707 | QC rfMRI cleaned inverse tSNR | GCST90006358 | 13.32 |
| 708 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320660 | 13.30 |
| 709 | Ever thought that life not worth living | Self-harm behaviours | UKBB00000225 | 13.27 |
| 710 | Gamma-glutamylglycine levels | GCST90199741 | 13.27 |
| 711 | aparc-pial rh area precentral | GCST90003197 | 13.23 |
| 712 | CA4/PECAM1 ratio | GCST90313586 | 13.23 |
| 713 | SERPINB6/TXNDC5 ratio | GCST90315832 | 13.23 |
| 714 | SNX9/STIP1 ratio | GCST90315864 | 13.20 |
| 715 | EGFR/FAP ratio | GCST90314613 | 13.18 |
| 716 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480 | ECGU000480 | 13.17 |
| 717 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 13.17 |
| 718 | GLOD4/MIF ratio | GCST90314939 | 13.17 |
| 719 | neutrophil (absolute count, maximum, inv-norm transformed) | GCST90475526 | 13.16 |
| 720 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466 | ECGU000466 | 13.16 |
| 721 | ATP5IF1/FXN ratio | GCST90313386 | 13.15 |
| 722 | CD40LG/TRAF2 ratio | GCST90313828 | 13.14 |
| 723 | AAGAB levels | GCST90617473 | 13.12 |
| 724 | Recent feelings of inadequacy | Depression | UKBB00000739 | 13.06 |
| 725 | MIA levels | GCST90469903 | 13.04 |
| 726 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186 | ECGU000186 | 13.03 |
| 727 | Disorders of iris and ciliary body (PheCode 379.5) | GCST90475899 | 13.02 |
| 728 | IL15RA levels | GCST90469555 | 12.99 |
| 729 | Physical decline (log-difference score) | GCST90565847 | 12.99 |
| 730 | Snoring | Sleep | UKBB00000784 | 12.96 |
| 731 | Thyroid cancer (PheCode 193) | GCST90475600 | 12.95 |
| 732 | Neutrophil count | GCST90025977 | 12.93 |
| 733 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468 | ECGU000468 | 12.92 |
| 734 | Daytime dozing / sleeping (narcolepsy) | Sleep | UKBB00000164 | 12.90 |
| 735 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 12.89 |
| 736 | Nontoxic nodular goiter | endocrine/metabolic | UKBB00000529 | 12.89 |
| 737 | F-dairy liking (derived food-liking factor) | GCST90094751 | 12.87 |
| 738 | CACNB3 levels | GCST90468523 | 12.85 |
| 739 | Phosphatidylethanolamine_40:6_[M-H]1- levels | GCST90060365 | 12.84 |
| 740 | Pain in limb (PheCode 773) | GCST90476270 | 12.83 |
| 741 | neutrophil (absolute count, mean, inv-norm transformed) | GCST90475529 | 12.80 |
| 742 | CCL14/CST3 ratio | GCST90313679 | 12.80 |
| 743 | ATOX1 levels | GCST90468385 | 12.79 |
| 744 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56 | ECGA000056 | 12.79 |
| 745 | AmygNuclei lh volume Medial-nucleus | GCST90002653 | 12.78 |
| 746 | CD48/SLAMF7 ratio | GCST90313842 | 12.77 |
| 747 | CLEC1B/EGF ratio | GCST90314089 | 12.75 |
| 748 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65 | ECGA000065 | 12.74 |
| 749 | Hereditary ataxia | FING00000610 | 12.70 |
| 750 | GP6/SELP ratio | GCST90314970 | 12.70 |
| 751 | Blood cell traits latent factor 12 (red cell) | GCST90559254 | 12.68 |
| 752 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454 | ECGU000454 | 12.68 |
| 753 | Ectopic pregnancy | FING00000487 | 12.68 |
| 754 | CD40LG/SERPINE1 ratio | GCST90313826 | 12.67 |
| 755 | aseg rh volume Putamen | GCST90002639 | 12.65 |
| 756 | Kidney volume | GCST90016670 | 12.63 |
| 757 | CASP10 levels | GCST90468542 | 12.63 |
| 758 | Disorders of iron metabolism (PheCode 275.1) | GCST90475743 | 12.61 |
| 759 | Other contact dermatitis | FING00000990 | 12.61 |
| 760 | SLAMF7/TXNDC15 ratio | GCST90315850 | 12.61 |
| 761 | TNFRSF10A levels | GCST90470899 | 12.60 |
| 762 | BAX/MAX ratio | GCST90313466 | 12.58 |
| 763 | NAGPA levels | GCST90242004 | 12.58 |
| 764 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476357 | 12.57 |
| 765 | CACYBP levels | GCST90468524 | 12.51 |
| 766 | BA-exvivo rh volume BA3b | GCST90002852 | 12.51 |
| 767 | HLA-DMA levels | GCST90241448 | 12.50 |
| 768 | ANXA3/HCLS1 ratio | GCST90313282 | 12.50 |
| 769 | Moderate-to-vigorous intensity physical activity during leisure time | GCST90104341 | 12.49 |
| 770 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476365 | 12.49 |
| 771 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55 | ECGA000055 | 12.47 |
| 772 | Fracture of lumbar spine and pelvis | FING00000556 | 12.47 |
| 773 | Total bile acid levels in pregnancy | GCST90454198 | 12.46 |
| 774 | SYTL4 levels | GCST90470795 | 12.46 |
| 775 | Histidine levels | GCST90243404 | 12.46 |
| 776 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490 | ECGU000490 | 12.44 |
| 777 | Left ventricular outflow tract obstruction (LVOTO), broad definition | FING00000717 | 12.44 |
| 778 | CPM/LAMP2 ratio | GCST90314215 | 12.43 |
| 779 | Witnessed sudden violent death | Traumatic events | UKBB00000917 | 12.42 |
| 780 | BACH1/DIABLO ratio | GCST90313437 | 12.42 |
| 781 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus R | GCST90003919 | 12.40 |
| 782 | APLP1 levels | GCST90468330 | 12.37 |
| 783 | BIRC2/CD40LG ratio | GCST90313517 | 12.37 |
| 784 | BRAP levels | GCST90468464 | 12.32 |
| 785 | Divergent concomitant strabismus | FING00000470 | 12.26 |
| 786 | Erythematous conditions (PheCode 695) | GCST90476177 | 12.24 |
| 787 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T489 | ECGU000489 | 12.22 |
| 788 | Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heel | UKBB00000321 | 12.21 |
| 789 | Myopia | FING00000853 | 12.20 |
| 790 | Depression or dysthymia | FING00000400 | 12.19 |
| 791 | CKMT1A or CKMT1B levels | GCST90468760 | 12.19 |
| 792 | DTI TBSS L3 Posterior thalamic radiation R | GCST90384552 | 12.19 |
| 793 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487 | ECGU000487 | 12.15 |
| 794 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225 | ECGU000225 | 12.14 |
| 795 | COL1A1 levels | GCST90468813 | 12.14 |
| 796 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278 | ECGU000278 | 12.13 |
| 797 | BA-exvivo rh thickness BA4a | GCST90003531 | 12.12 |
| 798 | rfMRI amplitudes (ICA100 node 38) | GCST90004626 | 12.11 |
| 799 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166 | ECGA000166 | 12.09 |
| 800 | ITGB1/VASN ratio | GCST90315232 | 12.08 |
| 801 | aparc-DKTatlas lh area postcentral | GCST90003254 | 12.07 |
| 802 | Right-hemisphere somatomotor network to putamen white-matter structural connectivity | GCST90302796 | 12.05 |
| 803 | Phosphatidate_34:2_[M-H]1- levels | GCST90060223 | 12.05 |
| 804 | CKAP4/IL4R ratio | GCST90314072 | 12.04 |
| 805 | STAB2 levels | GCST90470755 | 12.04 |
| 806 | HBEGF/LAT2 ratio | GCST90315032 | 12.01 |
| 807 | CD59/SCARB2 ratio | GCST90313859 | 12.00 |
| 808 | UBXN1 levels | GCST90471004 | 11.99 |
| 809 | Other strabismus | FING00001114 | 11.98 |
| 810 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187 | ECGU000187 | 11.95 |
| 811 | CD59/CST6 ratio | GCST90313857 | 11.94 |
| 812 | ATOX1/SPARC ratio | GCST90313375 | 11.94 |
| 813 | Recent feelings of foreboding | Anxiety | UKBB00000738 | 11.93 |
| 814 | LPP levels | GCST90469790 | 11.92 |
| 815 | FUT8/TNFSF12 ratio | GCST90314894 | 11.91 |
| 816 | T1 FreeSurfer BA rh V2 exvivo thickness | GCST90385571 | 11.89 |
| 817 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83 | ECGA000083 | 11.87 |
| 818 | ADAMTSL2 levels | GCST90468228 | 11.86 |
| 819 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483 | ECGU000483 | 11.86 |
| 820 | GRAP2/SNX9 ratio | GCST90314988 | 11.84 |
| 821 | T1 FreeSurfer DK rh superiorparietal thickness | GCST90385751 | 11.81 |
| 822 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 11.81 |
| 823 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75 | ECGA000075 | 11.80 |
| 824 | Osteomyelitis | FING00000911 | 11.79 |
| 825 | RABGAP1L levels | GCST90470416 | 11.78 |
| 826 | neutrophil (absolute count, minimum, inv-norm transformed) | GCST90475532 | 11.77 |
| 827 | EDAR/EGF ratio | GCST90314573 | 11.76 |
| 828 | ACY3 levels | GCST90468213 | 11.74 |
| 829 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 11.72 |
| 830 | ENDOU levels | GCST90469107 | 11.72 |
| 831 | PPP1R12A/SPARC ratio | GCST90315712 | 11.71 |
| 832 | Lignoceroylcarnitine (C24) levels | GCST90200137 | 11.68 |
| 833 | TNFSF11 levels | GCST90274844 | 11.66 |
| 834 | Charcot foot | FING00000268 | 11.64 |
| 835 | IDP dMRI TBSS L1 Inferior cerebellar peduncle L | GCST90004086 | 11.64 |
| 836 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 11.61 |
| 837 | PSCA levels | GCST90470352 | 11.60 |
| 838 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80 | ECGU000080 | 11.60 |
| 839 | aparc-DKTatlas rh thickness postcentral | GCST90003591 | 11.59 |
| 840 | wg lh intensity-contrast superiorfrontal | GCST90003819 | 11.59 |
| 841 | COL4A1 levels | GCST90468818 | 11.58 |
| 842 | PROS1 levels | GCST90470337 | 11.58 |
| 843 | IDP dMRI ProbtrackX L1 cgc r | GCST90004251 | 11.58 |
| 844 | CEP112 levels | GCST90468708 | 11.58 |
| 845 | Acetone levels | GCST90092805 | 11.57 |
| 846 | WWP2 levels | GCST90471080 | 11.56 |
| 847 | Pain type(s) experienced in last month - Knee pain | Pain | UKBB00000629 | 11.55 |
| 848 | KRT5 levels | GCST90469718 | 11.54 |
| 849 | SIGLEC7 levels | GCST90470635 | 11.54 |
| 850 | SH2B3 levels | GCST90470616 | 11.50 |
| 851 | ESAM/JAM2 ratio | GCST90314712 | 11.50 |
| 852 | PDE5A levels | GCST90470187 | 11.49 |
| 853 | Recent feelings of depression | Depression | UKBB00000737 | 11.49 |
| 854 | MED18/TBL1X ratio | GCST90315415 | 11.48 |
| 855 | C1R levels | GCST90468493 | 11.47 |
| 856 | MAN2B2 levels | GCST90469844 | 11.46 |
| 857 | Glutamine levels | GCST90092818 | 11.46 |
| 858 | Right molecular layer hippocampal volume (body) | GCST90267975 | 11.46 |
| 859 | VNN2 levels | GCST90618510 | 11.44 |
| 860 | Microalbumin urine | GCST90278639 | 11.44 |
| 861 | PDGFB levels | GCST90012016 | 11.43 |
| 862 | Blood cell traits latent factor 10 (platelet) | GCST90559252 | 11.43 |
| 863 | ICAM5 levels | GCST90241541 | 11.41 |
| 864 | CD74/NPDC1 ratio | GCST90313895 | 11.41 |
| 865 | Mid-point of the five least active hours of the day | GCST90061434 | 11.39 |
| 866 | IFNAR1 levels | GCST90469512 | 11.36 |
| 867 | F11R/GP1BA ratio | GCST90314722 | 11.35 |
| 868 | CALCOCO1/METAP2 ratio | GCST90313606 | 11.34 |
| 869 | aparc-a2009s rh volume G-occipital-sup | GCST90003018 | 11.34 |
| 870 | aparc-a2009s lh volume G-front-inf-Triangul | GCST90002938 | 11.31 |
| 871 | KIR2DL2 levels | GCST90469684 | 11.30 |
| 872 | Type of accommodation lived in - A flat, maisonette or apartment | Household | UKBB00000868 | 11.28 |
| 873 | DTI autoptx L2 slf r tract | GCST90385188 | 11.28 |
| 874 | HS6ST2 levels | GCST90469480 | 11.27 |
| 875 | DECR1 levels | GCST90468978 | 11.23 |
| 876 | Retinal detachment with retinal defect | sense organs | UKBB00000754 | 11.22 |
| 877 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224 | ECGU000224 | 11.20 |
| 878 | Use of antiglaucoma preparations and miotics | FING00001409 | 11.19 |
| 879 | aparc-a2009s lh area S-orbital-med-olfact | GCST90003359 | 11.16 |
| 880 | BST2/CEACAM1 ratio | GCST90313537 | 11.15 |
| 881 | MZB1/TNFRSF13B ratio | GCST90315509 | 11.11 |
| 882 | FOXO3/MAP3K5 ratio | GCST90314880 | 11.11 |
| 883 | Ptosis of eyelid | FING00001227 | 11.08 |
| 884 | NUDT2 levels | GCST90470106 | 11.07 |
| 885 | ALCAM/MSR1 ratio | GCST90313240 | 11.03 |
| 886 | DKK1/PDGFA ratio | GCST90314475 | 11.02 |
| 887 | Left ventricular end diastole inferoseptal wall thickness | GCST90278514 | 11.01 |
| 888 | ITGB1BP2/USP8 ratio | GCST90315223 | 10.99 |
| 889 | DAB2/ERBIN ratio | GCST90314361 | 10.99 |
| 890 | FABP2/RBP2 ratio | GCST90314757 | 10.97 |
| 891 | ASPSCR1 levels | GCST90468378 | 10.94 |
| 892 | Takes medication for Glaucoma? | GCST90475384 | 10.93 |
| 893 | PIK3AP1/PSMG3 ratio | GCST90315651 | 10.92 |
| 894 | BA-exvivo lh volume V2 | GCST90002845 | 10.91 |
| 895 | Atopic dermatitis | GCST90027161 | 10.90 |
| 896 | BA-exvivo rh volume BA3a | GCST90002851 | 10.90 |
| 897 | Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age) | GCST90239748 | 10.90 |
| 898 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 10.89 |
| 899 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 10.86 |
| 900 | Maternal care for other conditions predominantly related to pregnancy | FING00000791 | 10.84 |
| 901 | INPPL1 levels | GCST90469619 | 10.84 |
| 902 | Left-hemisphere dorsal attention network to putamen white-matter structural connectivity | GCST90302703 | 10.84 |
| 903 | SPARC levels | GCST90470718 | 10.83 |
| 904 | wg lh intensity-contrast temporalpole | GCST90003824 | 10.83 |
| 905 | DEFA1_DEFA1B/PTGDS ratio | GCST90314455 | 10.83 |
| 906 | CALCOCO1/MAP3K5 ratio | GCST90313605 | 10.82 |
| 907 | Acetone levels (UKB data field 23477) | GCST90269574 | 10.81 |
| 908 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | GCST90004369 | 10.79 |
| 909 | STAT5B levels | GCST90470759 | 10.78 |
| 910 | KLK8 levels | GCST90422316 | 10.77 |
| 911 | TXLNA levels | GCST90470989 | 10.76 |
| 912 | F2R/TNFRSF14 ratio | GCST90314739 | 10.75 |
| 913 | CANT1/VSIR ratio | GCST90313621 | 10.75 |
| 914 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54 | ECGA000054 | 10.74 |
| 915 | ESR1 levels | GCST90469155 | 10.74 |
| 916 | Granulocyte count | GCST004614 | 10.73 |
| 917 | IDP T1 FAST ROIs V cerebellum X | GCST90002588 | 10.71 |
| 918 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 10.70 |
| 919 | aparc-a2009s rh area G-precentral | GCST90003399 | 10.69 |
| 920 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 10.68 |
| 921 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 10.67 |
| 922 | CRADD/FKBP4 ratio | GCST90314238 | 10.65 |
| 923 | KLK8 levels | GCST90425492 | 10.64 |
| 924 | CDH3/NECTIN4 ratio | GCST90313952 | 10.64 |
| 925 | MESD/SNX9 ratio | GCST90315423 | 10.61 |
| 926 | CASP3/SERPINB9 ratio | GCST90313642 | 10.61 |
| 927 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 10.60 |
| 928 | Cancer (standard GWA) | GCST90267270 | 10.58 |
| 929 | DTI autoptx L3 ilf r tract | GCST90385208 | 10.57 |
| 930 | Percentage of invited food questionnaires completed | GCST90012790 | 10.52 |
| 931 | Citrate levels | GCST90497200 | 10.51 |
| 932 | CD40LG/EDAR ratio | GCST90313818 | 10.50 |
| 933 | Croissant liking | GCST90094748 | 10.47 |
| 934 | OSM/TGFA ratio | GCST90315590 | 10.47 |
| 935 | CST3/EFEMP1 ratio | GCST90314292 | 10.46 |
| 936 | DOK2/SNX9 ratio | GCST90314539 | 10.46 |
| 937 | Other specified disorders of external ear | FING00001104 | 10.45 |
| 938 | PNMA1 levels | GCST90470276 | 10.44 |
| 939 | Benign neoplasm: Adrenal gland | FING00000164 | 10.41 |
| 940 | CGREF1/FAM3C ratio | GCST90314032 | 10.40 |
| 941 | TREML1 levels | GCST90470961 | 10.40 |
| 942 | Mean corpuscular haemoglobin concentration | Blood count | UKBB00000448 | 10.36 |
| 943 | FST levels | GCST90469273 | 10.34 |
| 944 | DCXR levels | GCST90468964 | 10.32 |
| 945 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170 | ECGA000170 | 10.32 |
| 946 | MPHOSPH8 levels | GCST90469934 | 10.31 |
| 947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79 | ECGU000079 | 10.30 |
| 948 | DTI autoptx MD ilf l tract | GCST90385234 | 10.29 |
| 949 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26 | ECGA000026 | 10.26 |
| 950 | FUT8/PDGFA ratio | GCST90314890 | 10.26 |
| 951 | Urine glycocholenate sulfate* levels in chronic kidney disease | GCST90265292 | 10.25 |
| 952 | AHCY levels | GCST90468259 | 10.24 |
| 953 | CD8A levels | GCST90468655 | 10.24 |
| 954 | Pain in thoracic spine | FING00001139 | 10.22 |
| 955 | BA-exvivo lh thickness BA3b | GCST90003516 | 10.21 |
| 956 | Reticulocyte fraction of red cells | GCST004619 | 10.16 |
| 957 | CD74/JAM2 ratio | GCST90313893 | 10.15 |
| 958 | PM20D1 levels | GCST90470268 | 10.15 |
| 959 | Diacylglycerol (14:0_18:2) levels | GCST90024705 | 10.14 |
| 960 | CRADD/MAP4K5 ratio | GCST90314240 | 10.13 |
| 961 | ACVRL1/TNFRSF9 ratio | GCST90313160 | 10.12 |
| 962 | CCN2/ENO2 ratio | GCST90313712 | 10.12 |
| 963 | SERPINB1 levels | GCST90470589 | 10.12 |
| 964 | DAPP1/PMVK ratio | GCST90314396 | 10.11 |
| 965 | IDP T1 FAST ROIs R front operc cortex | GCST90002532 | 10.08 |
| 966 | DAB2/LYN ratio | GCST90314365 | 10.08 |
| 967 | Drink temperature | GCST90133002 | 10.07 |
| 968 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 10.06 |
| 969 | MCFD2/VSIR ratio | GCST90315411 | 10.06 |
| 970 | GMFG levels | GCST90469366 | 10.02 |
| 971 | aparc-Desikan rh area precentral | GCST90003130 | 10.01 |
| 972 | CANT1/NUDT5 ratio | GCST90313619 | 9.99 |
| 973 | ACVRL1/SCARB2 ratio | GCST90313157 | 9.98 |
| 974 | VSNL1 levels | GCST90471054 | 9.97 |
| 975 | CNPY4/MESD ratio | GCST90314152 | 9.95 |
| 976 | IL1RAP levels | GCST90469573 | 9.93 |
| 977 | N6-methyllysine levels in chronic kidney disease | GCST90257530 | 9.93 |
| 978 | Acquired toe deformities (PheCode 735.2) | GCST90476249 | 9.91 |
| 979 | IPCEF1/SPARC ratio | GCST90315186 | 9.91 |
| 980 | MB levels | GCST90469869 | 9.90 |
| 981 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 9.90 |
| 982 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220 | ECGU000220 | 9.89 |
| 983 | FKBP4/RWDD1 ratio | GCST90314840 | 9.89 |
| 984 | Glaucoma | GCST90018632 | 9.88 |
| 985 | CSF2 levels | GCST90468884 | 9.87 |
| 986 | Takes medication for Sleep apnea? | GCST90475258 | 9.86 |
| 987 | PPP1R2/TBL1X ratio | GCST90315720 | 9.86 |
| 988 | CAMK1D levels | GCST90240556 | 9.85 |
| 989 | IDP dMRI TBSS L3 Splenium of corpus callosum | GCST90004175 | 9.82 |
| 990 | Other retinal disorders | FING00001094 | 9.82 |
| 991 | Hearing aid user | Hearing | UKBB00000309 | 9.81 |
| 992 | NFKBIE levels | GCST90470039 | 9.80 |
| 993 | TGFBI levels | GCST90470845 | 9.80 |
| 994 | Sleep disorders | Episodic and paroxysmal disorders | UKBB00000775 | 9.77 |
| 995 | MITD1/SNX9 ratio | GCST90315454 | 9.74 |
| 996 | IDP dMRI ProbtrackX ISOVF str r | GCST90004549 | 9.74 |
| 997 | Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary Operations | UKBB00000577 | 9.74 |
| 998 | TNFRSF6B levels | GCST90470914 | 9.73 |
| 999 | CDH1 levels | GCST90468670 | 9.72 |
| 1000 | DFFA levels | GCST90468987 | 9.72 |